1996
DOI: 10.7326/0003-4819-125-1-199607010-00001
|View full text |Cite
|
Sign up to set email alerts
|

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

Abstract: Patients with symptomatic deep venous thrombosis, especially those without transient risk factors for deep venous thrombosis, have a high risk for recurrent venous thromboembolism that persists for many years. The post-thrombotic syndrome occurs in almost one third of these patients and is strongly related to ipsilateral recurrent deep venous thrombosis. These findings challenge the widely adopted use of short-course anticoagulation therapy in patients with symptomatic deep venous thrombosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

61
1,397
25
55

Year Published

1997
1997
2018
2018

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 1,952 publications
(1,538 citation statements)
references
References 0 publications
61
1,397
25
55
Order By: Relevance
“…21 It has been shown that recurrence of ipsilateral DVT is a strong predictor of PTS and that long periods of anticoagulation and wearing CS seems to prevent it. [40][41][42][43] In this study, there was a greater number of TG patients with ipsilateral rethrombosis among those who had CEAP≥3 than among thrombophilic patients with CEAP<3, but the difference did not attain statistical significance. We did not observe any difference between thrombophilic and control groups in terms of complaints or CEAP-based physical examination findings, in contrast with reports that have shown lower PTS incidence in patients with genetic thrombophilia.…”
Section: Discussioncontrasting
confidence: 58%
“…21 It has been shown that recurrence of ipsilateral DVT is a strong predictor of PTS and that long periods of anticoagulation and wearing CS seems to prevent it. [40][41][42][43] In this study, there was a greater number of TG patients with ipsilateral rethrombosis among those who had CEAP≥3 than among thrombophilic patients with CEAP<3, but the difference did not attain statistical significance. We did not observe any difference between thrombophilic and control groups in terms of complaints or CEAP-based physical examination findings, in contrast with reports that have shown lower PTS incidence in patients with genetic thrombophilia.…”
Section: Discussioncontrasting
confidence: 58%
“…The recurrence rate of venous thromboembolism in the general population (non-APS patients) was quite well defined in 1996 by Prandoni et al [32] who showed a 30% cumulative incidence of recurrence after 8 years of followup (i.e. 3.75% patients per year, in subjects off therapy).…”
Section: Conclusion and Commentsmentioning
confidence: 98%
“…Furthermore, different illnesses carry different associations, cancer being perceived as leading to a lingering, painful death and heart disease being seen as "a good way to go" (Walter et al 2004, Hallowell, in press). In this respect, deep vein thrombosis is close to heart disease, because it usually manifests as an identifiable "event," although the mortality associated with DVT is low (1-2%) in comparison to myocardial infarction, but as many as 25% of patients with DVT will develop a postthrombotic syndrome (associated with chronic pain and other symptoms usually in the leg) and have a significant risk of reoccurrence (up to 30%) over the next 10 years (Prandoni et al 1996).…”
Section: Perceptions Of Genetic Riskmentioning
confidence: 99%